Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 16551-16600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06635850
A Study of Mosliciguat in PH-ILD
PHASE2Recruiting
120 participants
Started: Oct 29, 2024 · Completed: Jan 31, 2028
6 conditions1 sponsor18 locations
NCT06481592
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
PHASE2Recruiting
60 participants
Started: Oct 29, 2024 · Completed: Nov 30, 2029
1 condition1 sponsor10 locations
NCT06657768
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
PHASE1Recruiting
88 participants
Started: Oct 29, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor7 locations
NCT06605534
Leveraging the Emergency Department (LEAD) Study
NARecruiting
100 participants
Started: Oct 29, 2024 · Completed: Oct 30, 2026
1 condition2 sponsors10 locations
NCT06473103
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
NARecruiting
52 participants
Started: Oct 29, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06560684
CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR
PHASE2Recruiting
150 participants
Started: Oct 29, 2024 · Completed: May 31, 2026
1 condition1 sponsor8 locations
NCT06663813
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
NARecruiting
400 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT06658743
Designing Team Clinic for Youth with Type 2 Diabetes
N/ARecruiting
74 participants
Started: Oct 29, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT07042035
Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
N/ARecruiting
240 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT06366633
Web-based Mind-body Program for Comorbid Nontraumatic Upper-extremity Condition and Risky Substance Use
NARecruiting
12 participants
Started: Oct 29, 2024 · Completed: Jul 31, 2025
4 conditions2 sponsors1 location
NCT06574789
Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
PHASE2Recruiting
232 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor7 locations
NCT06647342
The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
PHASE4Recruiting
55 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2027
4 conditions3 sponsors2 locations
NCT06754358
Clinical Application Comparison of Two Femtosecond Laser Systems
PHASE1Recruiting
100 participants
Started: Oct 29, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06483789
Efficacy and Safety of HB-1 for Panic Disorder
PHASE2Recruiting
240 participants
Started: Oct 29, 2024 · Completed: Feb 28, 2026
2 conditions1 sponsor20 locations
NCT06622655
Clinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy
NARecruiting
40 participants
Started: Oct 29, 2024 · Completed: Jul 31, 2026
1 condition4 sponsors6 locations
NCT06524648
International Pilot Study for Dual Non-invasive Assesment of Embryo Development
N/ARecruiting
200 participants
Started: Oct 29, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor8 locations
NCT06210555
Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing
N/ARecruiting
96 participants
Started: Oct 29, 2024 · Completed: Aug 1, 2029
5 conditions2 sponsors2 locations
NCT07119463
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
PHASE2Recruiting
112 participants
Started: Oct 29, 2024 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT06580990
Neck-specific Exercises Effectively Improves Whiplash-associated Disorders.
NARecruiting
102 participants
Started: Oct 29, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06550674
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
NARecruiting
50 participants
Started: Oct 29, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06673238
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
PHASE1Recruiting
96 participants
Started: Oct 29, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06334315
Oral Contraceptive Pill (OCP) Pharmacogenomics
PHASE4Recruiting
700 participants
Started: Oct 29, 2024 · Completed: May 31, 2028
2 conditions2 sponsors2 locations
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
PHASE3Recruiting
196 participants
Started: Oct 29, 2024 · Completed: Dec 12, 2031
4 conditions1 sponsor18 locations
NCT06546969
Chemoimmunotherapy Combined with Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
PHASE1Recruiting
15 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor2 locations
NCT06533826
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
PHASE2Recruiting
357 participants
Started: Oct 29, 2024 · Completed: Aug 1, 2038
4 conditions3 sponsors9 locations
NCT06529679
Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction
NARecruiting
30 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06575270
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
N/ARecruiting
92 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06713902
Extracellular Vesicles in Fibrin Gel for Cartilage Repair
N/ARecruiting
51 participants
Started: Oct 29, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06554353
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
N/ARecruiting
50 participants
Started: Oct 29, 2024 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05916950
The THOR IDE Study
NARecruiting
155 participants
Started: Oct 29, 2024 · Completed: Dec 31, 2027
4 conditions3 sponsors27 locations
NCT06655896
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
PHASE2Recruiting
86 participants
Started: Oct 29, 2024 · Completed: Aug 30, 2032
1 condition1 sponsor55 locations
NCT06511674
Vulnerability and Risk of Neuropathic Pain in Cancer
NARecruiting
625 participants
Started: Oct 28, 2024 · Completed: Jun 30, 2028
3 conditions1 sponsor18 locations
NCT06656312
Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
NARecruiting
548 participants
Started: Oct 28, 2024 · Completed: Sep 14, 2025
1 condition1 sponsor1 location
NCT06579885
Ocular Complications of Mpox in the Democratic Republic Congo
N/ARecruiting
62 participants
Started: Oct 28, 2024 · Completed: Jun 29, 2025
2 conditions3 sponsors1 location
NCT06422741
Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers
NARecruiting
22 participants
Started: Oct 28, 2024 · Completed: Feb 28, 2026
3 conditions2 sponsors2 locations
NCT06565156
Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
NARecruiting
60 participants
Started: Oct 28, 2024 · Completed: Jan 31, 2026
5 conditions1 sponsor17 locations
NCT06589661
The Patient AS EDUcator in Anesthesia: Exploring the Patients' Experience During and After Unexpected Cesarean Delivery Under General Anesthesia to Inform Anesthetic Practice
N/ARecruiting
15 participants
Started: Oct 28, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06835907
Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study
NARecruiting
58 participants
Started: Oct 28, 2024 · Completed: Dec 30, 2029
1 condition1 sponsor1 location
NCT06674447
Awareness Among PT Regarding Sensory Integration Therapy on CP Population
N/ARecruiting
200 participants
Started: Oct 28, 2024 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06850597
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
PHASE2Recruiting
30 participants
Started: Oct 28, 2024 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06049680
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
PHASE4Recruiting
100 participants
Started: Oct 28, 2024 · Completed: Sep 30, 2026
4 conditions1 sponsor4 locations
NCT06621914
Is Low-load Resistance Training With Blood Flow Restriction Feasible During Rehabilitation of Military Personnel With Lower Limb Injuries? Phase One RCT.
NARecruiting
28 participants
Started: Oct 28, 2024 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT06040970
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
PHASE1/PHASE2Recruiting
54 participants
Started: Oct 28, 2024 · Completed: Sep 7, 2026
2 conditions1 sponsor1 location
NCT06392113
Developing a Falls Management Tool for Adults With ID-POC
N/ARecruiting
30 participants
Started: Oct 28, 2024 · Completed: Jan 31, 2025
2 conditions2 sponsors2 locations
NCT06487221
Avutometinib and Defactinib in Diffuse Gastric Cancer
PHASE2Recruiting
27 participants
Started: Oct 28, 2024 · Completed: May 30, 2029
2 conditions2 sponsors1 location
NCT06541990
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
NARecruiting
50 participants
Started: Oct 28, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT07058896
Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impairment: A Feasibility Study
NARecruiting
18 participants
Started: Oct 28, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06504407
BINGO: Bridging Knowledge, Increasing Awareness
NARecruiting
90 participants
Started: Oct 28, 2024 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT06652100
Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults
N/ARecruiting
800 participants
Started: Oct 28, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors12 locations
NCT06638996
Acute Psychological and Physiological Effects of Cannabigerol
NARecruiting
100 participants
Started: Oct 28, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location